跳至主要内容
临床试验/NCT00501878
NCT00501878已完成4 期

2.5% and 10% Phenylephrine for Mydriasis in Diabetic Patients With Darkly Pigmented Irides

Khon Kaen University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2007年5月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
2
主要终点
Pupil diameters were measured.

研究概览

简要总结

To compare the clinical efficacy and systemic side effects between 2.5% and 10% phenylephrine for mydriasis in diabetic patient with darkly pigmented irides.

详细描述

One hundred patients with diabetes from Srinagarind Hospital Eye Clinic were enrolled and randomized into two groups by block randomization. In group I (50 patients), 1% tropicamide combined with 2.5% phenylephrine were administered to dilate pupil whereas 1% tropicamide combined with 10% phenylephrine were used in Group II (50 patients). Pupil diameter, blood pressure and heart rate were measured before and after eye drop instillations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diabetic patients

排除标准

  • history of intraocular surgery or laser treatment,
  • any ocular diseases that might affect pupil size such as glaucoma,uveitis,Horner's syndrome, Adies' pupil,
  • history of allergy to any drug used, and
  • hypertension

结局指标

主要结局

Pupil diameters were measured.

时间窗: before and after phenylephrine eye drop instillations

次要结局

  • blood pressure and heart rate were measured(before and after phenylephrine eye drop instillations)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yosanan Yospaiboon

Professor

Khon Kaen University

研究点 (2)

Loading locations...

相似试验